We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
After a volatile January, Wall Street started February on a strong footing.The S&P 500, the Dow Jones and the Nasdaq Composite added about 3%, 3.1% and 3.4%, respectively, past week (as of Feb 5, 2021). The S&P 500 and the Nasdaq Composite Index are hovering around new highs.
Solid corporate earnings and expectations of a fat stimulus by U.S. President Joe Biden’s administration have renewed the appeal for the riskier assets. The stronger-than-expected results so far in the fourth quarter have led analysts to raise their estimates for the coming quarters (read: Ride Market Rally With High-Beta ETFs & Stocks).
Against this backdrop, below we highlight a few leveraged ETF areas that surged last week.
Marijuana
Marijuana stocks started February on a strong note. The latest surge came on the heels of the news that three Democratic senators led by Majority Leader Chuck Schumer said they would make marijuana reform legislation a key consideration in the current Congress, boosting hopes for a federal legalization.
Also, the latest deal activity in the space has strengthened the bullish case for these stocks. This is especially true as Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock.
Global X Cannabis ETF (up 26.6%), Spinnaker ETF Series The Cannabis ETFTHCX) (up 25.2%), Amplify Seymour Cannabis ETF (CNBS) (up 24.7%) and Advisorshares Pure Cannabis ETF (YOLO) (up 23.6%) were the clear gainers of the above-mentioned moves (read: Top ETF Stories of January Worthy of Attention in February).
Travel
Hopes of a sooner-than-expected global economic recovery amid vaccine launches and rollouts as well as a gradual return to normalcy have boosted travel stocks. ETFMG Travel Tech ETF (AWAY - Free Report) thus added about 15.8% (read: Leisure Stocks & ETFs Rally on Strong Vaccine Hopes).
Mining Stocks
Uranium equities had a great week thanks to positive business fundamentals. As quoted on the S&P Global Market Intelligence report, TD Securities analyst Greg Barnes wrote in a Feb 3 note “that a subreddit named r/UraniumSqueeze was created Feb 1 on the Reddit website amid a retail-driven rally in silver markets and had already accrued about 500 members. Users on the social media site called on other day-by-day investors to invest in the radioactive metal.” The very news probably boosted uranium prices and the mining companies’ ETF like Northshore Global Uranium Mining ETF (URNM - Free Report) , which is up 15.4% (see all Materials ETFs here).
3D Printing
3D Printing has been on a tear lately thanks to the growing transition to automation, smart technologies and decentralization of factories. 3D Printing ETF (PRNT - Free Report) (up 14.9%) was a clear winner of this trend shift.
Blockchain
Blockchain ETF Transformational Data Sharing Amplify ETF (BLOK - Free Report) added about 14.7%. The fund is actively managed and seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of transformational data sharing technologies.
In recent weeks, the fund has been a beneficiary of the bitcoin rally. Since “the blockchain in Bitcoin literally acts a ledger; it keeps track of the balances for all users and updates them as money changes hands,” BLOK has every reason to gain traction.
Biotech
The pandemic has also a triggered a race to introduce vaccine and treatment, thereby bolstering investing opportunities in the biotech sector. Bioshares Biotech Clinical TrialBBC) (up 12.6%) was the prime winner of the rally (read: How Will Biotech ETFs React to Q4 Earnings?).
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
6 ETF Areas Up At Least 10% Last Week
After a volatile January, Wall Street started February on a strong footing.The S&P 500, the Dow Jones and the Nasdaq Composite added about 3%, 3.1% and 3.4%, respectively, past week (as of Feb 5, 2021). The S&P 500 and the Nasdaq Composite Index are hovering around new highs.
Solid corporate earnings and expectations of a fat stimulus by U.S. President Joe Biden’s administration have renewed the appeal for the riskier assets. The stronger-than-expected results so far in the fourth quarter have led analysts to raise their estimates for the coming quarters (read: Ride Market Rally With High-Beta ETFs & Stocks).
Against this backdrop, below we highlight a few leveraged ETF areas that surged last week.
Marijuana
Marijuana stocks started February on a strong note. The latest surge came on the heels of the news that three Democratic senators led by Majority Leader Chuck Schumer said they would make marijuana reform legislation a key consideration in the current Congress, boosting hopes for a federal legalization.
Also, the latest deal activity in the space has strengthened the bullish case for these stocks. This is especially true as Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock.
Global X Cannabis ETF (up 26.6%), Spinnaker ETF Series The Cannabis ETF THCX) (up 25.2%), Amplify Seymour Cannabis ETF (CNBS) (up 24.7%) and Advisorshares Pure Cannabis ETF (YOLO) (up 23.6%) were the clear gainers of the above-mentioned moves (read: Top ETF Stories of January Worthy of Attention in February).
Travel
Hopes of a sooner-than-expected global economic recovery amid vaccine launches and rollouts as well as a gradual return to normalcy have boosted travel stocks. ETFMG Travel Tech ETF (AWAY - Free Report) thus added about 15.8% (read: Leisure Stocks & ETFs Rally on Strong Vaccine Hopes).
Mining Stocks
Uranium equities had a great week thanks to positive business fundamentals. As quoted on the S&P Global Market Intelligence report, TD Securities analyst Greg Barnes wrote in a Feb 3 note “that a subreddit named r/UraniumSqueeze was created Feb 1 on the Reddit website amid a retail-driven rally in silver markets and had already accrued about 500 members. Users on the social media site called on other day-by-day investors to invest in the radioactive metal.” The very news probably boosted uranium prices and the mining companies’ ETF like Northshore Global Uranium Mining ETF (URNM - Free Report) , which is up 15.4% (see all Materials ETFs here).
3D Printing
3D Printing has been on a tear lately thanks to the growing transition to automation, smart technologies and decentralization of factories. 3D Printing ETF (PRNT - Free Report) (up 14.9%) was a clear winner of this trend shift.
Blockchain
Blockchain ETF Transformational Data Sharing Amplify ETF (BLOK - Free Report) added about 14.7%. The fund is actively managed and seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of transformational data sharing technologies.
In recent weeks, the fund has been a beneficiary of the bitcoin rally. Since “the blockchain in Bitcoin literally acts a ledger; it keeps track of the balances for all users and updates them as money changes hands,” BLOK has every reason to gain traction.
Biotech
The pandemic has also a triggered a race to introduce vaccine and treatment, thereby bolstering investing opportunities in the biotech sector. Bioshares Biotech Clinical TrialBBC) (up 12.6%) was the prime winner of the rally (read: How Will Biotech ETFs React to Q4 Earnings?).
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>